OTC Bulletin Board S & P Company Insight for APPLIED DNA SCIENCES
Profile
	Business Summary: Applied DNA Sciences, Inc. provides botanical DNA encryption, embedment, and authentication solutions in the United States and Europe.   Address   25 Health Sciences Drive   Suite 113   Stony Brook , NY 11790   Phone: 631-444-6862   Website: http://www.adnas.com Auditor   RBSM   McLean Transfer Agent   Securities Transfer Corp. Employees:  7 ShareHolders:  1283 Founded:  1983 Domicile:  Nevada
Background
	Applied DNA Sciences, Inc. provides botanical DNA encryption, embedment, and authentication solutions in the United States and Europe. Its solutions protect companies, governments, and consumers from counterfeiting, fraud, piracy, product diversion, identity theft, and unauthorized intrusion into physical locations and databases. The company's SigNature Program provides a means to incorporate its SigNature DNA Markers in, and then authenticate and identify a range of items, such as artwork and collectibles, fine wine, consumer products, digital media, financial instruments, identity cards, and other official documents. Applied DNA Sciences was founded in 1983 and is headquartered in Stony Brook, New York. History:  INCORPORATED in Nevada Apr. 20, 1998, as DCC Acquisition Corp.; and on Dec. 20, 1998, merged DataLink Capital Corp., a Florida corporation, to effect a change in domicile to Nevada. The company's name changed to ProHealth Medical Technologies, Inc. Oct. 27, 1999; and to Applied DNA Sciences, Inc. in connection with the merger, effective Oct. 31, 2002, of the company's wholly owned subsidiary, Applied DNA Sciences, Inc., into the company. The company acquired Applied DNA Sciences, Inc. (incorporated Sept. 16, 2002) on Oct. 21, 2002, for 11,000,000 Common shares. DataLink Capital Corp., the Florida corporation, was incorporated Jan. 26, 1983, as Datalink Systems, Inc.; name changed to Datalink Capital Corp. Apr. 29, 1987, to Midland Capital Resources, Inc. Apr. 26, 1991, and to DataLink Capital Corp. Sept. 29, 1997.
Management
	Management Officers Position  James  Hayward Chairman, President, Investor Relations Contact & Chief Executive Officer  Kurt H. Jensen Chief Financial Officer, Chief Accounting Officer & Controller  Ming-Hwa Benjamin Liang Secretary Directors  Scott R. Griffiths  James  Hayward  Yacov  Shamash  Jesse  Shelmire  Sanford R. Simon
Annual Report
	Annual Report   Income Statement   2007 2006 Sales 121,920 18,900 Cost of sales 23,073 15,639 General and administrative expenses 12,096,444 8,530,354 Impairment of intangible assets -- 5,655,011 Research and development 110,845 153,191 Depreciation and Amortization 432,582 1,370,299 Net gain in revaluation of debt derivative and warrant liabilities 1,387,932 16,844,837 Other income, net 977 79,488 Interest expense, net 2,152,718 3,628,968 Net loss (13,304,833) (2,410,237) Share earns. basic ($0.10) ($0.02) Share earns. diluted ($0.10) ($0.02) Average shares 135,229,885 116,911,022   Balance Sheet   2007 ASSETS Current Assets: Cash 25,185 Restricted cash 399,920 Prepaid expenses 101,000 Total Current Assets 526,105 Net Property, Plant and Equipment 105,537 Deposits 13,822 Capitalized finance costs 29,503 Intangible assets 1,736,821 TOTAL ASSETS 2,411,788 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable and accrued liabilities 13,215,975 Note payable 740,405 Other current liabilities 399,920 Total Current Liabilities 14,356,300 STOCKHOLDERS' EQUITY Convertible Preferred Stock, par value $0.001 per share 6 Common Stock, par value $0.50 per share 180,281 Additional paid in capital 128,448,584 Accumulated deficit (140,573,383) Total Stockholders' Equity (11,944,512) TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 2,411,788 Preferred Shares 60,000 Common Shares 180,281,661
Interim Report
	Interim Report      Data Not Available
Pro Forma Report
	Pro Forma Report      Data Not Available
Quarterly Report
	Quarterly Report Information      Quarterly Revenue, US$ Year Quarter Revenue   2008   1 120,000   2008   2 210,000   2007   1 Nil   2007   2 Nil   2007   3 Nil   2007   Full Year 120,000   2006   1 Nil   2006   2 Nil   2006   3 20,000   2006   Full Year 20,000   2005   1 Nil   2005   2 Nil   2005   Full Year Nil   2004   1 Nil   2004   2 Nil   2004   3 Nil   2004   Full Year Nil   2003   3 Nil   2003   Full Year Nil     Quarterly Net Income, US$ Year Quarter Revenue   2008   1 (2,130,000)   2008   2 (1,330,000)   2007   1 (670,000)   2007   2 (9,370,000)   2007   3 1,810,000   2007   Full Year (13,300,000)   2006   1 (2,440,000)   2006   2 3,360,000   2006   3 760,000   2006   Full Year (2,410,200)   2005   1 (12,370,000)   2005   2 (16,810,000)   2005   Full Year (52,610,400)   2004   1 (7,540,000)   2004   2 (2,440,000)   2004   3 2,230,000   2004   Full Year (19,358,300)   2003   3 (330,000)   2003   Full Year (3,445,000)     Quarterly EPS, US$ Year Quarter Revenue   2008   1 (.01)   2008   2 (.01)   2007   1 (.01)   2007   2 (.08)   2007   3 (.02)   2007   Full Year (.10)   2006   1 (.02)   2006   2 .03   2006   3 .01   2006   Full Year (.02)   2005   1 (.45)   2005   2 (.31)   2005   Full Year (.82)   2004   1 (.41)   2004   2 (.12)   2004   3 (.10)   2004   Full Year (.93)   2003   3 (.02)   2003   Full Year (.27)
Stock Data
	Capitalization as of 03/31/2008:     Authorized Shares Outstanding Shares Preferred $0.001 par 10,000,000 60,000so1 Common $0.001 par 250,000,000 192,136,603   LONG TERM DEBT: None.   Common $0.0001 par   Stockholders:  01/10/2008, 1283. Transfer Agent:  Securities Transfer Corp.   Frisco , TX   OTC Bulletin Board( Primary): APDN   Exchange Year High Low OTC Bulletin Board 2007 0.2800 0.0800 OTC Bulletin Board 2006 0.3700 0.0700 OTC Bulletin Board 2005 1.8300 0.1600 OTC Bulletin Board 2004 3.5500 0.4200 OTC Bulletin Board 2003 3.5400 2.0000 OTC Bulletin Board 2002 2.5000 0.0500   DIVIDENDS: Common $0.0001 par: None.       so1Closely held.